Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E3EY
|
||||
Former ID |
DCL000521
|
||||
Drug Name |
Elsamitrucin
|
||||
Synonyms |
Elsamicin; Elsamitrucina; Elsamitrucine; Elsamitrucinum; Chartreusin analog; Elsamicin A; Antibiotic BBM 2478A; BBM 2478A; BMY 28090; SPI 28090; BBM-2478A; BMS-181171; BMY-28090; BU-2478A; Elsamitrucin [USAN:INN]; Elsamitrucina [INN-Spanish]; Elsamitrucine [INN-French]; Elsamitrucinum [INN-Latin]; E-87/025; 10-O-Elsaminosylelsarosylchartarin; 2-Amino-2,6-dideoxy-3-O-methyl-D-galactose
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Late-stage solid tumors [ICD9: 140-199, 210-229; ICD10:C00-C75, C7A, C7B, D10-D36, D3A] | Phase 2 | [527240] | ||
Company |
Spectrum
|
||||
Structure |
Download2D MOL |
||||
Formula |
C33H35NO13
|
||||
Canonical SMILES |
CC1C(C(C(C(O1)OC2C(OC(C(C2(C)O)O)C)OC3=CC=CC4=C3C5=C6C7<br />=C(C=CC(=C7C(=O)O5)C)OC(=O)C6=C4O)N)OC)O
|
||||
InChI |
1S/C33H35NO13/c1-11-9-10-16-19-17(11)29(38)46-25-18-14(24(36)21(20(19)25)30(39)44-16)7-6-8-15(18)45-32-28(33(4,40)27(37)13(3)43-32)47-31-22(34)26(41-5)23(35)12(2)42-31/h6-10,12-13,22-23,26-28,31-32,35-37,40H,34H2,1-5H3
|
||||
InChIKey |
MGQRRMONVLMKJL-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 22260-51-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
ChEBI ID |
ChEBI:3182
|
||||
Target and Pathway | |||||
Target(s) | DNA topoisomerase II | Target Info | Modulator | [527240] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.